Nuvation Bio (NUVB)
Develops cancer medicines led by IBTROZI and a focused oncology pipeline.
$6.10
After hours0.00 (0.00%)
At close$6.10(+0.49%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 66.55% | 233.67M shares | |
|---|---|---|---|
| 251 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 25.72% | 90.30M shares | |
| 11 holders · as of Jul 17, 2026 | |||
| Other | ≈ 7.73% | 27.15M shares | |
| remainder | |||
351.12M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
251 holders · 233.67M shares · 42 new positions · 152 increased · 53 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 52.23M | 14.88% | +240.7K | Aug 13, 2026 |
| BlackRock, Inc. | 27.63M | 7.87% | +2.53M | Aug 7, 2026 |
| Decheng Capital LLC | 25.95M | 7.39% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 11.92M | 3.39% | +293.3K | Aug 13, 2026 |
| Omega Fund Management, LLC | 8.08M | 2.30% | 0 | Aug 14, 2026 |
| Laurion Capital Management LP | 7.82M | 2.23% | −2.6K | Aug 13, 2026 |
| State Street Corp | 7.37M | 2.10% | +585.9K | Aug 7, 2026 |
| Geode Capital Management, LLC | 6.24M | 1.78% | +381.2K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 15.00% | 50.60M | 13G | May 12, 2025 |
| BlackRock, Inc. | 6.40% | 21.71M | 13G | Jul 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Gary Hattersleyofficer: CHIEF SCIENTIFIC OFFICER | Sale | 100,000 | $7.09 | 0 |
| Jun 23, 2026 | Philippe Sauvageofficer: Chief Financial Officer | Sale | 47,668 | $6.01 | 12,673 |
| Jun 23, 2026 | Kerry Wentworthofficer: CHIEF REGULATORY OFFICER | Sale | 63,000 | $6.02 | 53,000 |
| Jun 23, 2026 | Stacy Markelofficer: CHIEF PEOPLE OFFICER | Sale | 125,000 | $6.03 | 32,591 |
| Jun 9, 2026 | Robert Mashaldirector | Purchase | 25,000 | $4.73 | 225,000 |
| Apr 17, 2026 | Dongfang Liuofficer: CHIEF MEDICAL OFFICER | Sale | 50,000 | $5.02 | 18,000 |
| Apr 17, 2026 | Kerry Wentworthofficer: CHIEF REGULATORY OFFICER | Sale | 36,750 | $5.01 | 53,000 |
| Apr 6, 2026 | Kerry Wentworthofficer: CHIEF REGULATORY OFFICER | Sale | 200,000 | $4.52 | 53,000 |
| Dec 1, 2025 | Dongfang Liuofficer: CHIEF MEDICAL OFFICER | Sale | 150,000 | $7.82 | 18,000 |
| Nov 25, 2025 | Dongfang Liuofficer: CHIEF MEDICAL OFFICER | Sale | 10,000 | $7.50 | 18,000 |
House and Senate disclosures
Not reported.